Table 2.
Net annualized patient out-of-pocket costs associated with cancer by phase of care, SEER-Medicare 2007-2013a,b,c
| Cancer site | Medical services (Medicare parts A and B) |
Prescription drugs covered through pharmacy benefit (Medicare part D) |
Medical services and prescription drugs |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Initial | Continuing | End-of-life cancer death | Initial | Continuing | End-of-life cancer death | Initial | Continuing | End-of-life cancer death | |
| Bladder | $1472 | $503 | $3195 | $154 | $119 | $201 | $1626 | $622 | $3396 |
| Brain | $5751 | $975 | $5901 | $522 | $247 | $479 | $6273 | $1222 | $6380 |
| Breast | $2206 | $384 | $2852 | $202 | $167 | $275 | $2408 | $551 | $3127 |
| Cervix uteri | $3038 | $349 | $3148 | −$6 | −$36 | $29 | $3032 | $313 | $3177 |
| Colorectal | $2641 | $482 | $3857 | $66 | $30 | $91 | $2706 | $512 | $3948 |
| Esophagus | $4196 | $664 | $4459 | $336 | $113 | $210 | $4532 | $777 | $4669 |
| Hodgkin lymphoma | $3802 | $617 | $4201 | $378 | $75 | $384 | $4180 | $693 | $4585 |
| Kidney | $1693 | $606 | $3388 | $309 | $222 | $938 | $2003 | $827 | $4326 |
| Leukemia | $1973 | $797 | $5176 | $642 | $413 | $582 | $2615 | $1210 | $5758 |
| AML | $6093 | $1056 | $7039 | $1267 | $335 | $639 | $7359 | $1392 | $7678 |
| CLL | $1318 | $790 | $3393 | $122 | $117 | $333 | $1440 | $907 | $3726 |
| CML | $1572 | $799 | $4342 | $2456 | $2341 | $946 | $4028 | $3141 | $5288 |
| Liver | $2746 | $970 | $2745 | $577 | $466 | $773 | $3323 | $1436 | $3517 |
| Lung | $3140 | $780 | $4003 | $460 | $309 | $546 | $3601 | $1089 | $4550 |
| NSCLC | $3050 | $776 | $3930 | $470 | $312 | $588 | $3519 | $1089 | $4518 |
| SCLC | $4461 | $861 | $4474 | $325 | $236 | $274 | $4786 | $1097 | $4748 |
| Melanoma | $662 | $340 | $2980 | $123 | $95 | $440 | $786 | $434 | $3420 |
| Myeloma | $3562 | $1532 | $4132 | $2576 | $1593 | $1818 | $6138 | $3125 | $5950 |
| Non-Hodgkin lymphoma | $3767 | $848 | $4940 | $219 | $88 | $297 | $3987 | $936 | $5237 |
| Oral cavity or pharynx | $3029 | $465 | $3978 | $161 | $36 | $186 | $3191 | $500 | $4164 |
| Ovary | $3166 | $902 | $3907 | $154 | $6 | $142 | $3320 | $908 | $4049 |
| Pancreas | $4280 | $1083 | $4158 | $819 | $519 | $871 | $5099 | $1602 | $5029 |
| Prostate | $1819 | $335 | $2830 | $95 | $48 | $533 | $1914 | $382 | $3363 |
| Stomach | $3116 | $534 | $4007 | $308 | $145 | $164 | $3424 | $678 | $4172 |
| Thyroid | $1354 | $415 | $3347 | $228 | $177 | $434 | $1582 | $592 | $3782 |
| Uterus | $1944 | $337 | $3187 | $40 | $15 | $146 | $1984 | $352 | $3333 |
| All sites combined | $2200 | $466 | $3823 | $243 | $127 | $448 | $2443 | $593 | $4271 |
Includes patients diagnosed with in-situ and invasive cancers. AML = acute myeloid leukemia; CLL = chronic lymphocytic leukemia; CML = chronic myeloid leukemia; NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer; SEER = Surveillance, Epidemiology, and End Results Program.
Costs associated with cancer are estimated as the difference between cancer cases and matched controls. All estimates in 2019 US dollars.
Out-of-pocket costs estimated from patient responsibility for medical services (including infusion drugs) under Medicare Parts A/B claims. Out-of-pocket costs for oral prescription drugs estimated directly from Medicare Part D claims.